Hereby, we present the case of a 50-year-old woman with 5-year history of chronic idiopathic myelofibrosis who was referred to our institution after she had noted a lump in the breast. Histological examination of the lesion removed from her left breast yielded the diagnosis of extramedullary hematopoiesis in the breast. On the basis of our experience in this particular patient and on the basis of the data in the literature, we discuss the value of different more or less invasive diagnostic procedures, such as sonography, mammography, fine needle aspiration biopsy and surgical excision with histological examination of removed tissue in obtaining the diagnosis of myeloid metaplasia in breast.
Introduction
Chronic idiopathic myelofibrosis (CIM) is a cronic myeloproliferative disease (CMPD) characterized by bonemarrow fibrosis which often leads to extramedullary hematopoiesis (EMH) in the spleen, liver and lymph nodes [1] . Foci of EMH, i.e., myeloid metaplasia (MM), can also occur in other organs, particularly in the suprarenal glands, kidneys, intestine, lungs, mediastinum, thymus, skin, synovial membranes, mesentherium, epidural space as well as in the breast [1] . There are few reports in the literature describing the cases of MM of the breast in patients with CIM [2] [3] [4] [5] [6] [7] . The foci of EMH in the breast may appear in the context of widely disseminated disease [3] , as the only clinically identifiable tumor [4] [5] [6] or as an incidental finding accompanying breast carcinoma [7] . In this report we present the patient with a known history of CIM which was referred to our institute because of the lump in her left breast and we discuss different diagnostic and therapeutic procedures used in this particular patient with MM of the breast.
Case report
A 50-year-old patient with five-year history of CIM was referred to our institution after she had noted a lump in her left breast. Her menstrual cycle was still regular and her familial history as regards breast cancer was negative. A 50 x 40 mm large induration was palpated in the outer upper quadrant of the left breast, while the ipsilateral axillary lymph nodes were not enlarged. The right breast and the regional lymph nodes were without evidence of disease on palpation.
On bilateral mammography the breast tissue showed an asymmetric pattern of confluent densities, which were more prominent in the left breast, no circumscribed masses or microcalcinations were detected ( Figure I ). The examination of a fine needle aspiration biopsy (FNAB) drawn from the upper outer quadrant of the left breast was consistent with a benign process. Afterwards, the patient underwent surgical excision of the palpable mass in her left breast. On frozen section no definitive diagnosis was given, although invasive carcinoma, possibly lobular, was suspected. When paraffin sections were obtained, the lesion was diagnosed as EMH. Microscopically, the breast tissue appeared sclerotic, with uneven distribution of ductal and acinar structures. The intra-and interlobular stroma was infiltrated with dissociated cells; among them giant pleomorphic megakaryocytes with multilobated and focally hyperchromatic nuclei and abundant eosinophilic cytoplasm were most conspicuous. The rest of the infiltrate varied morphologically and was composed of immature and mature myeloid cells (Figure 2 ). Rare foci of normoblasts were also observed. Immunohistochemically, megakaryocytes showed positive reaction for factor VHI-related antigen; white cells and precursors were myeloperoxidase, lysozyme 1 and CD43 positive, and normoblasts were positive for glycophorin A (Figure 2 ).
Four months after surgery, a new lump, measuring 5 mm, appeared right above the postoperative scar. Again, bilateral mammography was performed, which showed disorders in the tissue structure in the region of the postoperative scar in the outer upper quadrant of the left breast, along with evidence of diffuse densities in both breasts. On that occasion, sonography of the left breast was performed for the first time. The image showed two smooth, homogenous and echo-poor for- (Figure 4 ). Taking into account the history of the disease, sonographic findings and the results of cytological examination, we have concluded that this patient had a recurrence of extramedullary hematopoiesis in the left breast, and should therefore be subjected to regular follow-up only.
At the same time, the patient complained of severe fatigue, nausea and myalgia. The blood count showed progression of normocytic, normochromic anemia, with an increased number of leukocytes and thrombocytes. Bone X-ray showed an increased bone density consistent with osteosclerosis whereas CT-scan of the abdomen demonstrated a marked enlargement of the spleen and a slight enlargement of the liver, while the rest of the findings were within normal limits. Also X-ray of the lung and NMR of the thoracolumbar spine failed to show any foci of extramedullary hematopoiesis. The patient was treated with hydroxiurea for 10 months, however, no improvement in the patient's performance status and blood count was seen. Both masses in the left breast showed clinical and well as sonographical evidence of stagnation. As there was a histocompatible donor of the bone marrow available, the patient underwent bone-marrow transplantation. A follow-up examination five months after the bone marrow transplantation showed neither clinical nor sonographical evidence of tumorous formations in the breasts.
Discussion
Although MM of the breast is a rare condition, it should be taken into account particularly in patients with a known history of CIM. Patients with advanced CIM frequently present with foci of extramedullary hematopoiesis in several organs, including the breast [1] [2] [3] . Case presentations reported in the literature, show that EMH in the breast can also be the only sign of extramedullary hematopoiesis. These patients are otherwise free of any other symptoms and usually do not require treatment for CIM [4] [5] [6] [7] . Ignoring the possibility of EMH renders the differential diagnosis of a tumor mass in the breast of these patients difficult.
Clinically, EMH of the breast manifests itself either as a delineated mass which can be sometimes quite large [4] , or as a larger area of poorly delineated induration, the latter being the case in our patient. The skin is supposed to be intact without any clinical signs of inflammation or hematoma. At the same time, ipsilateral axillary lymph nodes or nodes elsewhere can be enlarged, since the foci of EMH may present in the lymph nodes as well. Martinelli et al. reported on a case of a 74-yearold woman with CIM, in whom, apart from a 2 cm large tumorous mass in the breast, enlarged ipsilateral axillary lymph nodes were found and histological evidence of EMH in the breast as well as in the lymph nodes was detected [5] .
The type of breast lesion can not be defined solely on the basis of clinical examination. Additional information can be obtained by radiological examinations, such as mammography and sonography. According to our observation, which is consistent with those reported by Zonderland et al. [6] , the foci of EMH in the breast are visible on sonography as smooth, delineated, hypoechogenic formations. Unlike carcinoma, which is usually well visible on mammography particularly in older patients, the foci of EMH can not be detected by X-ray. Therefore, despite its limitations, sonography is an important diagnostic tool in patients with a breast lump and a history of CIM. Since a similar sonographic features can also be observed in other breast lesions, such as lymphoma of the breast, additional microscopic examination is required for the final diagnosis. Fine-needle aspiration biopsy is a noninvasive, highly specific but poorly sensitive method used in the diagnosis of tumorous lesions. The sensitivity of this method can be improved by sonographically or radiographically guided aspiration. This has also been proved in our patient, in whom a blind FNAB performed on the first occurrence of breast disease did not yield relevant findings, while the sonographically guided FNAB on recurrence of the disease showed the presence of EMH in the tumorous mass and confirmed the diagnosis of recurrent EMH in the breast. Fine-needle aspiration biopsy has already been reported as a useful method in the diagnosis of EMH in other sites [8, 9] . However, a definitive diagnosis of EMH and a reliable exclusion of other diseases, particularly of carcinoma, is possible only on the basis of tru-cut biopsy or surgical excision of the lesion which allows for the histological examination of the affected tissue. One should be aware that there is also a possibility of mixed lesions in the breast, Setsu et al. [7] reported on a 49-year-old patient with CIM who presented with coexistent EMH and tubular carcinoma in the same breast tumor. Therefore, if the growth of the breast lesion, which was diagnosed as EMH by tru-cut biopsy, does not correlate with the course of the CIM in each particular patient, surgical excision of the lesion should be performed.
Although highly reliable, histological diagnosis of EMH in the breast may also be difficult, if clinical data are not available to the pathologist and frozen section diagnosis is requested, as in our case. Therefore a close collaboration between pathologist and clinician is needed for a proper diagnosis. When clinical history of CMPD is available, microscopical diagnosis of EMH of the breast should not pose particular problems to pathologist and immunohistochemistry will usually not be mandatory.
Based on our experience and the data from the literature, we believe that for the final confirmation of the EMH in the breast and exclusion of carcinoma in patients with a history of CIM and a palpable tumor in the breast, a tru-cut biopsy or a surgical removal of the lesion with the histological examination of the tissue is mandatory. However, in patients presenting with a recurrent lesion after the removal of foci of EMH from the breast, which was also the case in our patient, a sonographically guided FNAB, which is less traumatic for patients, may also be appropriate diagnostic approach. If the lesion is sonographically visible as a homogenous, echo-poor mass and by FNAB the presence of normal epithelium and hematopoietic cells in the smear is revealed, the immediate surgical removal of the lesion is not necessary and the patient could only be monitored by regular follow up. If so, it is expected that the growth of the breast lump will depend on the control of the primary disease, which has been proved by disappearance of both recurrent masses in the left breast of our patient after bone marrow transplantation. Since every nodule in the breast may conceal a carcinoma, all patients without surgical removal of the lesion should be under close surveillance and the lesion should be removed immediately if any discrepancy between the course of primary disease and lesion growth is noted.
